RecruitingExcessive Daytime Sleepiness
A Study of ORX142 in Healthy Adult Subjects, Including Subjects 18 to 80 Years of Age
Eligible age
18–80 yrs
Accepts
All genders
Locations
3 states
Healthy volunteers
Yes
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
Characterize the safety, tolerability and pharmacokinetics of ORX142 following single and multiple doses.
Sponsor: Centessa Pharmaceuticals (UK) Limited
Where it's recruiting
Source: ClinicalTrials.gov · NCT07082829 · last updated 2025-12-24